The 50-to-64-year-olds received either the new combo shot or a combination of Fluarix and Spikevax. The 65-and-older cohort received either mRNA-1083 or a combination of high-dose Fluzone and ...

GSK supports annual flu immunization by getting FLULAVAL and FLUARIX to patients in advance of flu season PHILADELPHIA, July 11, 2024--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) today announced it ...

Both FLULAVAL and FLUARIX will be available in a 0.5mL, single-dose, pre-filled syringe and are indicated for people six months of age and older. According to the US Centers for Disease Control ...

For patients age 50 to 64, the trial compared the combination vaccine against GSK PLC’s GSK Fluarix flu vaccine and Spikevax. Back To Top ...

The latest data was collected from two arms of a larger study that involved around 8,000 people - one tested the combination against GSK's Fluarix in adults aged 50 to 64 and another against ...

Moderna’s late-stage trial for its COVID-flu combination vaccine yielded positive results, the pharmaceutical and biotechnology company announ c ed Monday. The combination vaccine, which Moderna ...

The latest data was collected from two arms of a larger study that involved around 8,000 people — one tested the combination against GSK’s Fluarix in adults aged 50 to 64 and another against ...

and in the younger group it compared the combination shot against Spikevax and GSK’s shot Fluarix. In both age groups, Moderna said participants receiving the combination vaccine generated ...

The latest data was collected from two arms of a larger study that involved around 8,000 people – one tested the combination against GSK’s Fluarix in adults aged 50 to 64 and another against ...

These include egg-based vaccines (Vaxigrip Tetra, Fluarix Tetra, Afluria Quad, FluQuadri and Influvac Tetra), cell-based vaccines (Flucelvax Quad), adjuvanted vaccines (Fluad Quad) and high-dose ...

Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides ...